Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/27659
Title: Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data
Authors: Corbett, A
Williams, G
Creese, B
Hampshire, A
Hayman, V
Palmer, A
Filakovzsky, A
Mills, K
Cummings, J
Aarsland, D
Khan, Z
Ballard, C
Issue Date: 1-Nov-2023
Publisher: Elsevier
Citation: Corbett, A. et al. (2023) 'Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data', The Lancet Healthy Longevity, 2023, 4 (11), pp. e591 - e599. doi: 10.1016/S2666-7568(23)00187-3.
Abstract: Copyright © 2023 The Author(s). Background: Although the long-term health effects of COVID-19 are increasingly recognised, the societal restrictions during the COVID-19 pandemic hold the potential for considerable detriment to cognitive and mental health, particularly because major dementia risk factors—such as those related to exercise and dietary habits—were affected during this period. We used longitudinal data from the PROTECT study to evaluate the effect of the pandemic on cognition in older adults in the UK. Methods: For this longitudinal analysis, we used computerised neuropsychology data from individuals aged 50 years and older participating in the PROTECT study in the UK. Data were collected from the same participants before the COVID-19 pandemic (March 1, 2019–Feb 29, 2020) and during its first (March 1, 2020–Feb 28, 2021) and second (March 1, 2021–Feb 28, 2022) years. We compared cognition across the three time periods using a linear mixed-effects model. Subgroup analyses were conducted in people with mild cognitive impairment and in people who reported a history of COVID-19, and an exploratory regression analysis identified factors associated with changes in cognitive trajectory. Findings: Pre-pandemic data were included for 3142 participants, of whom 1696 (54·0%) were women and 1446 (46·0%) were men, with a mean age of 67·5 years (SD 9·6, range 50–96). Significant worsening of executive function and working memory was observed in the first year of the pandemic across the whole cohort (effect size 0·15 [95% CI 0·12–0·17] for executive function and 0·51 [0·49–0·53] for working memory), in people with mild cognitive impairment (0·13 [0·07–0·20] and 0·40 [0·36–0·47]), and in people with a history of COVID-19 (0·24 [0·16–0·31] and 0·46 [0·39–0·53]). Worsening of working memory was sustained across the whole cohort in the second year of the pandemic (0·47; 0·44–0·49). Regression analysis indicated that cognitive decline was significantly associated with reduced exercise (p=0·0049; executive function) and increased alcohol use (p=0·049; working memory) across the whole cohort, as well as depression (p=0·011; working memory) in those with a history of COVID-19 and loneliness (p=0·0038; working memory) in those with mild cognitive impairment. In the second year of the pandemic, reduced exercise continued to affect executive function across the whole cohort, and associations were sustained between worsening working memory and increased alcohol use (p=0·0040), loneliness (p=0·042), and depression (p=0·014) in those with mild cognitive impairment, and reduced exercise (p=0·0029), loneliness (p=0·031) and depression (p=0·036) in those with a history of COVID-19. Interpretation: The COVID-19 pandemic resulted in a significant worsening of cognition in older adults, associated with changes in known dementia risk factors. The sustained decline in cognition highlights the need for public health interventions to mitigate the risk of dementia—particularly in people with mild cognitive impairment, in whom conversion to dementia within 5 years is a substantial risk. Long-term intervention for people with a history of COVID-19 should be considered to support cognitive health.
Description: Data sharing: Individual de-identified participant data that underlie this reported study are available as per the PROTECT study protocol up to 10 years after the study end date. Investigators wishing to access the data require approval through the PROTECT study committee, which can be sought by applying through the PROTECT study with a full analysis proposal. Investigators will need to sign a data access agreement. Approved requests will be able to access data from a secure web link for up to 5 years subject to approval. For further information, contact protect.data@exeter.ac.uk.
Supplementary Material is available online at: https://www.sciencedirect.com/science/article/pii/S2666756823001873#sec1 .
URI: https://bura.brunel.ac.uk/handle/2438/27659
DOI: https://doi.org/10.1016/S2666-7568(23)00187-3
Other Identifiers: ORCID iD: Byron Creese https://orcid.org/0000-0001-6490-6037
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).567.84 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons